Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ANTONIO ABBATE

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1184849168
CMS profile
190369
Location
CHARLOTTESVILLE, VA

General Payments · PY2018–2024

$168,726.35

  • Reported across 143 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$68,050.23

39 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Kiniksa Pharmaceuticals International, plc $39,534.75 25
Novo Nordisk AS $21,086.76 5
Novo Nordisk AS $7,163.14 5
NOVARTIS PHARMACEUTICALS CORPORATION $214.54 2
Amgen Inc. $36.39 1
ZOLL Circulation Inc $14.65 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $12,397.74 21
PY2019 $10,791.30 15
PY2020 $4,875.00 5
PY2021 $9,057.76 9
PY2022 $13,315.29 19
PY2023 $50,239.03 35
PY2024 $68,050.23 39

Payment records · PY2024 (39)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $36.39 04/25/2024 Food and Beverage Undisputed 01/23/2026 1111507393 CMS
Kiniksa Pharmaceuticals International, plc $1,675.00 02/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1154883539 CMS
Kiniksa Pharmaceuticals International, plc $133.08 02/22/2024 Food and Beverage Undisputed 01/23/2026 1154883535 CMS
Kiniksa Pharmaceuticals International, plc $2,345.00 02/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1154883533 CMS
Kiniksa Pharmaceuticals International, plc $135.00 04/04/2024 Food and Beverage Undisputed 01/23/2026 1154883525 CMS
Kiniksa Pharmaceuticals International, plc $103.61 04/07/2024 Food and Beverage Undisputed 01/23/2026 1154883583 CMS
Kiniksa Pharmaceuticals International, plc $3,350.00 04/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1154883523 CMS
Kiniksa Pharmaceuticals International, plc $156.78 04/10/2024 Travel and Lodging Undisputed 01/23/2026 1154883529 CMS
Kiniksa Pharmaceuticals International, plc $124.25 04/11/2024 Food and Beverage Undisputed 01/23/2026 1154883527 CMS
Kiniksa Pharmaceuticals International, plc $60.00 04/15/2024 Travel and Lodging Undisputed 01/23/2026 1154883519 CMS
Kiniksa Pharmaceuticals International, plc $630.32 04/15/2024 Travel and Lodging Undisputed 01/23/2026 1154883521 CMS
Kiniksa Pharmaceuticals International, plc $630.32 04/15/2024 Travel and Lodging Undisputed 01/23/2026 1154883569 CMS
Kiniksa Pharmaceuticals International, plc $3,350.00 04/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1154883517 CMS
Kiniksa Pharmaceuticals International, plc $3,115.50 09/27/2024 Consulting Fee Undisputed 01/23/2026 1154883421 CMS
Kiniksa Pharmaceuticals International, plc $80.00 09/30/2024 Travel and Lodging Undisputed 01/23/2026 1154883559 CMS
Kiniksa Pharmaceuticals International, plc $4.80 09/30/2024 Travel and Lodging Undisputed 01/23/2026 1154883561 CMS
Kiniksa Pharmaceuticals International, plc $535.91 09/30/2024 Travel and Lodging Undisputed 01/23/2026 1154883563 CMS
Kiniksa Pharmaceuticals International, plc $90.00 11/05/2024 Food and Beverage Undisputed 01/23/2026 1154883411 CMS
Kiniksa Pharmaceuticals International, plc $174.98 11/05/2024 Travel and Lodging Undisputed 01/23/2026 1154883551 CMS
Kiniksa Pharmaceuticals International, plc $16,080.00 11/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1154883553 CMS
Kiniksa Pharmaceuticals International, plc $165.77 11/05/2024 Travel and Lodging Undisputed 01/23/2026 1154883555 CMS
Kiniksa Pharmaceuticals International, plc $415.45 11/05/2024 Travel and Lodging Undisputed 01/23/2026 1154883557 CMS
Kiniksa Pharmaceuticals International, plc $70.59 11/21/2024 Food and Beverage Undisputed 01/23/2026 1154883543 CMS
Kiniksa Pharmaceuticals International, plc $3,350.00 12/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1154883541 CMS
Kiniksa Pharmaceuticals International, plc $78.39 12/19/2024 Travel and Lodging Undisputed 01/23/2026 1154883545 CMS
Kiniksa Pharmaceuticals International, plc $2,680.00 12/19/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1154883547 CMS
Novartis Pharmaceuticals Corporation $101.26 06/18/2024 Food and Beverage Undisputed 01/23/2026 1086749321 CMS
Novartis Pharmaceuticals Corporation $113.28 11/17/2024 Food and Beverage Undisputed 01/23/2026 1086749337 CMS
Novo Nordisk AS $80.65 10/01/2024 Food and Beverage Undisputed 01/23/2026 1096551913 CMS
Novo Nordisk AS $244.26 10/01/2024 Travel and Lodging Undisputed 01/23/2026 1096552443 CMS
Novo Nordisk AS $12,981.25 10/01/2024 Consulting Fee Undisputed 01/23/2026 1096552861 CMS
Novo Nordisk AS $7,276.87 10/01/2024 Travel and Lodging Undisputed 01/23/2026 1096553305 CMS
Novo Nordisk AS $503.73 10/01/2024 Travel and Lodging Undisputed 01/23/2026 1096553339 CMS
Novo Nordisk Inc $2,712.50 03/05/2024 Consulting Fee Undisputed 01/23/2026 1096817104 CMS
Novo Nordisk Inc $1,162.50 03/22/2024 Consulting Fee Undisputed 01/23/2026 1097838812 CMS
Novo Nordisk Inc $82.63 08/05/2024 Food and Beverage Undisputed 01/23/2026 1096927354 CMS
Novo Nordisk Inc $3,100.00 09/20/2024 Consulting Fee Undisputed 01/23/2026 1097838818 CMS
Novo Nordisk Inc $105.51 11/04/2024 Food and Beverage Undisputed 01/23/2026 1096605523 CMS
ZOLL Circulation Inc $14.65 08/31/2024 Food and Beverage Undisputed 01/23/2026 1067523057 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.